Smolinski appears on CNBC/PBS Nightly Business Report on Healthcare under Trump Administration
December 8, 2016 | Smolinski interviewed
CNBC video (link)

Opinion: Drug Pricing in a Trump America
Smolinski column
Morning Consult article (link)

Smolinski on CNBC: Tom Price as Trump’s Pick for HHS Secretary
Smolinski interviewed
CNBC transcript (link)

LISTEN: How our next president could affect drug prices
Smolinski interviewed
STAT News podcast (link)

BPC Praises Draft Chronic Care Bill, National Coalition On Health Care Urges Quick Passage
Smolinski quoted
Inside Health Policy (subscription required)

Smolinski on CNBC: Hospitals already experienced taper from ACA
Smolinski interviewed
CNBC video (link)

Opinion: The Public Plan Endgame
Smolinski column
Morning Consult article (link)

Will the Blues be next to leave ObamaCare?
Smolinski quoted
The Hill article (link)

Can 21st Century Cures Get a Fair Shake in an Election Year?
Smolinski column
Morning Consult article (link)

CMS To Pilot Pre-Enrollment Verification For SEPs In 2017
Smolinski quoted
Inside Health Policy (subscription required)

Value Frameworks Are Expanding For Drugs & Devices
Smolinski column
Morning Consult article (link)

DOJ files lawsuits to block mergers of insurance giants
Smolinski quoted
Politico article (link)

Not Waiting for the Feds, Some States Are Tackling Drug Pricing
Smolinski column
Morning Consult article (link)

Smolinski interviewed on CNBC about the government’s new inversions rule and the Pfizer-Allergan merger
CNBC video (link)

Final Medicare Advantage rate policies a mixed bag for insurers
Smolinski quoted
Modern Healthcare article (link)

U.S. to raise payments to insurers for Medicare Advantage 2017 plans
Smolinski quoted
Reuters article (link)

Ipsita Smolinski provides the policy outlook in an IMS Health Conference panel “End of the World as We Know It? The Impact of the 2016 US Payer Mergers on Drug Prices and Formularies”
Panel included Ana Gupte of Leerink Swan and Tevi Troy of the American Health Policy Institute
Politico Pro (subscription required)

Medicare Advantage Proposal Mostly Good News for Insurers
Smolinski quoted
Politico Pro (subscription required)

U.S. Proposes Hike in Medicare Advantage Payments; Insurer Shares Rise
Smolinski quoted
Reuters article (link)

Corporate winners of Obama budget still face long odds
Smolinski quoted
Reuters article (link)

Even as Clinton Bashes Drugmakers, Insurers May Still Feel Heat
Smolinski quoted
Bloomberg article (link)

Are Consumer Genomics Taking Off?
Smolinski column
Morning Consult article (link)

Capitol Street is proud to sponsor Brewer’s Ball 2016, fundraiser for the Cystic Fibrosis Foundation
Brewer’s Ball (link)

Race To Enrollment Finish Line, CBO Officially Lowers 2016 Projections
Smolinski quoted
Inside Health Policy

Biopharmaceutical Pros Address Rising Drug Prices on CNBC
Ipsita Smolinski, Capitol Street; Dr. Ron Cohen, Acorda; Dr. Peter Bach, Memorial Sloan Kettering Center for Health Policy
CNBC video (link)

Capitol Street hosts Consumer Genomics panel at 2016 JPMorgan Healthcare Conference
Capitol Street’s Ipsita Smolinski and JPMorgan’s Tycho Peterson convened a panel with 23andMe’s Anne Wojcicki, Cornell Weill’s Chris Mason, Helix’s Justin Kao, and Ancestry.com’s Ken Chahine. The President’s Precision Medicine initiative has spurred discussion on the value of large cohorts, accessing databases for therapeutics and the best path forward between the government and private sector.
JP Morgan Healthcare Conference – San Francisco, CA

Capitol hosts discussion with CMS Acting Administrator Any Slavitt at 2016 JPMorgan Healthcare Conference
During the January 11 session moderated by Ipsita Smolinski, Slavitt broke the news about CMS plans to fix Obamacare Exchange issues. He detailed his plan to refine mid-year special enrollment period issues along with enhanced risk adjustment for health plans. Much of this was spurred by UnitedHealth (and other issuer) concerns about how costly mid-year enrollees negatively impact the risk pool.
JP Morgan Healthcare Conference – San Francisco, CA

2015

Smolinski moderates Biosimilars panel at FDA-CMS annual summit
Capitol Street’s Ipsita Smolinski moderated a panel titled “Biosimilars Hit The Market: Now What?” at the December 2015 summit in Washington, DC. The panel included Kim Greco of Amgen, Ivan Blanerik of Boehringer Ingelheim, Carlos Sattler of Sandoz, Christine Simmon of GPHA, Krista Carver of Covington & Burlington LLP, and Frank Hallinan of Validant.
JP Morgan Healthcare Conference – San Francisco, CA

Has DC Crossed the Rubicon in Curbing Drug Prices?
Morning Consult article (link)

UnitedHealth move a ‘wake-up call’ for the White House: Analyst
CNBC video (Smolinski interviewed)

Hospitals Face Payment Cuts at Outpatient Sites in Budget
Bloomberg article (Smolinski quoted)

Smolinski provides health policy and financial markets outlook for key sectors
Sunovion Pharmaceuticals meeting – Orlando, FL

Contracting and Pricing Requirements for Drugs, Devices and Other Products and Services Under the VA’s Federal Supply Schedule Contracts
Smolinski provides address at American Bar Association Federal Drug Pricing Conference – Washington, DC (link)

CEOs Unplugged – Legislative and Policy Issues Facing the MedTech Industry
Smolinski moderates AdvaMed panel with CEO of Becton Dickinson – Vince Fortenza, Cepheid – John Bishop, AdvaMed – Steve Ubl, and CVRX – Nadim Yared (link)

Health Care Insiders Commend PhRMA For Expected Hire of AdvaMed CEO
Inside Health Policy (Smolinski quoted)

History offers a reality check on proposals to trim drug prices
Politico Pro (Smolinski quoted)

2016 Obamacare Preview: Heading into Open Season
Morning Consult article (link)

Drug Prices: How High is Too High?
Morning Consult article (link)

As Cures Clears the House, Silence in the Senate on FDA Reform
Morning Consult article (Smolinski quoted)

CNBC interview on Supreme Court decision to uphold Obamacare subsidies
CNBC video (Smolinski interviewed)

AHIP’s Ignagni moving to head up troubled N.Y. insurer
Modern Healthcare article (Smolinski quoted)

Politico Pro: Energy and Commerce votes to send Cures bill to House
Politico Pro (Smolinski quoted)

Allyson Schwartz named CEO of Medicare Advantage lobbying group
Modern Healthcare article (Smolinski quoted)

Value-Based Tsunami Creates Winners and Losers
Morning Consult article (link)

Medicare program gets harder to cut
The Hill article (Smolinski quoted)

Medicare Advantage plans nab 1.25% raise for 2016
Modern Healthcare article (Smolinski quoted)

Interchangeability Will Spur BioSimilar Market, But Big Hurdles Remain
Inside Health Policy (Smolinski quoted)

U.S. proposes 0.9 percent cut in 2016 Medicare Advantage payments
Reuters article (Smolinski quoted)

Finally, Biosimilars On The Horizon
Morning Consult article (link)

Smolinski interviewed on CNBC about the Economics of a Measles Outbreak
CNBC video (link)

As New Ebola Cases Wane, It’s Full Steam Ahead on Vaccines
Morning Consult article (link)

CMS’ Value-Based Pay Goals Raise Stakes For SGR Bill
Inside Health Policy article (Smolinski quoted)

Capitol Street hosts a fireside chat with NIH Director Francis Collins, MD, PhD @ the JPMorgan Healthcare Conference.
JP Morgan Healthcare Conference 2015

Capitol Street moderates panel on the DC Outlook for Diagnostic and Lab Testing @ the JPMorgan Healthcare Conference.
JP Morgan Healthcare Conference 2015

Specialty Formulary Exclusions Gaining Traction
Morning Consult article (link)

2014

Smolinski provides the post-election healthcare outlook for “Lilly Advocacy Dialogues on Discovery”
Capitol Hill event hosted by Eli Lilly Dec 2014

Outlook for Obamacare Year 2: Underpromise and Overdeliver?
Morning Consult article (link)

Smolinski on Medicare Advantage versus Obamacare enrollment figures & transparency
Politico article (link)

Novel Antobiotics Need a Dose of Incentives
Morning Consult article (link)

Smolinski serves as panelist at Pharmaceutical Pricing Conference & Contracting Conference in Philadephia, PA: (1) pharmacoeconomic discussion of recouping R&D costs in pricing models and (2) specialty drug pricing: payer and PBM perspective, Sept 22-23, 2014
PPCC conference website (link)

Will the Dems Halt Inversions – Or Not?
Morning Consult article (link)

Smolinski to moderate panel featuring Edwards CEO Michael Mussallem at the AdvaMed 2014 MedTech Conference in Chicago, IL (Oct 6-8)
AdvaMed conference website (link)

Will the Courts Save (or Dismantle) Obamacare?
Morning Consult article (link)

Is ACA legislation slowly being dismantled?
CNBC video (link)

The Fight Grows Around Specialty Drug Pricing
Morning Consult article (link)

Smolinski keynotes S&P Health Care 2014 Conference: June 3, 2014
Conference agenda (link)

Medicare Advantage and the ‘Potomac Two-Step’
Morning Consult article (link)

U.S. government rolls back proposed Medicare Advantage cut
Reuters article (link)

Capitol Street Sponsors 10th Annual Brewers’ Ball to Support Cystic Fibrosis Research
Cystic Fibrosis Foundation (link)

Ipsita Smolinski, Capitol Street, and Tycho Peterson, JPMorgan, Lead a Discussion on Gene Patenting, Innovation and Personalized Medicine
32nd Annual JP Morgan Healthcare Conference (link)

Smolinski on 2014 DC Outlook for Biotech
BioCentury TV video (link)

2013

Smolinski moderates Diagnostic Payment Panel
American Association for Cancer Research | AdvamedDx conference Oct 2013 (link)

Smolinski provides luncheon keynote address
American Bar Association: Health Law Section meeting Oct 2013

Survey Finds Talks On Rates Between Hospitals, QHPs Moving Slowly
Inside Health Policy article (link)

Double-digit health insurer rate hate hike trends going into Obamacare
CNBC video (link)

United Healthcare’s cautious stance on upcoming Exchange marketplace
Inside Health Policy

Healthcare reform’s need for cost controls, possibly lower subsidies, and a discussion of end-of-life care
Seeking Alpha interview (link)

Smolinski moderates diagnostic and lab policy discussion panel
JPMorgan Healthcare Conference Jan 2013

2012

Physicians brace for Medicare Doc Fix cliff
CNBC article (link)

Pricey medical devices and drugs under scrutiny at the Medicare agency
Bloomberg BNA

Proposed health reform marketplace actuarial value and essential health benefit rules
Bloomberg BNA

Double hit looms for doctors, hospitals under sequestration
Politico article (link)

Smolinski provides federal healthcare outlook
Acute Long Term Hospital Association (ALTHA) event May 2012

House Votes to Kill Medical Device Tax
Reuters article (link)

2011

Biosimilar Pathway Pre-IND requests at FDA
Inside Health Policy

Super Committee Urged To Alter Coverage For Some Low-Income Medicare Beneficiaries
Kaiser Health News article (link)

Americans turned to public health insurance in 2010
Reuters article (link)

Who Wins if Republicans Repeal Health Reform Law?
California Health Line article (link)

Smolinski provides federal healthcare reimbursement and regulatory outlook
Medtronic conference Feb 2011

Investors Get Bullish on Health Insurance
Politico article (link)

2010

Discussing President Obama’s health care efforts, with Joshua Raskin, of Barclays Capital; Ipsita Smolinski, of Capitol Street; Lisa Gill, JPMorgan
CNBC video (link)

Insurance advisory commission medical loss ratio guidelines
Reuters article (link)

NAIC releases draft insurance exchange regulation
The Hill article (link)

U.S. studies conflict on Glaxo diabetes drug risk
Reuters article (link)

FDA Panel Meets on Glaxo’s Avandia
Bloomberg TV (Smolinski interviewed)

Smolinski provides federal healthcare outlook
JPMorgan Healthcare Credit conference Apr 2010

Analysts Agree: Health Care Bill Will ‘Destroy’ Individual Markets: Ipsita Smolinski, president and health care analyst at Capitol Street, and Carl McDonald, health care analyst and managed care analyst at Oppenheimer, discussed their views
CNBC video and article (link)

2009

Betting on Healthcare Reform: Ipsita Smolinski, a health care analyst at Capitol Street, and Les Funtleyder, a health care strategist at Miller Tabak
CNBC video (link)